Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">IPO Radar: Four IPOs Price With Jounce Therapeutics (JNCE) & REV Group (REVG) Leading the Pack<strong>IPOs Opening Today:</strong><br/> <ul><li><strong>Jounce Therapeutics (JNCE):</strong> The clinical stage immunotherapy focused on transforming treatment of cancer by enabling immune system to attack tumors priced its <strong>up-sized</strong> 6.4 million share IPO at $16, above the $13-$15 price range.</li></ul><ul><li><strong>REV Group (REVG): </strong>The designer, manufacturer, and distributor of specialty vehicles & aftermarket parts priced its 12.5 million share IPO at $22, <strong>above</strong> the $19-$21 expected price range.</li></ul><ul><li><strong>JELD-WEN (JELD)</strong>: The leading door and window manufacturer priced its 25.0 million share IPO at $23, the <strong>high-end</strong> of the $21-$23 expected price range. </li></ul><ul><li><strong>Jagged Peak Energy (JAG):</strong> The oil & natural gas company focused on acquiring & developing unconventional assets in the Southern Delaware Basin priced its <strong>downsized</strong> 31.6 million share IPO at $15, <strong>below</strong> the $16-$18 expected price range. </li></ul><p><br/> <strong>Postponed IPOs</strong>:</p><ul><li><strong>Visterra (VIST):</strong> The clinical-stage biopharma focused on designing anti-body-based therapies intended to be as effective as single-dose administration is now listed as day-to-day. The company was expected to price its 3.9 million share IPO within a range of $12-$14.</li></ul></td> </tr></table>"